Technology

Carium Enhances Care Experience Platform with Customizable Care Pathways

Published

3 years ago

March 23, 2023

Carium also plans future release of developer stack, enabling further customization

PETALUMA, Calif., March 23, 2023 /PRNewswire/ — Carium, a Care Experience Platform (CXP), is now offering extensive customization enhancements through its Care Pathways implementations.

Carium enhances care experience platform with customizable care pathways and announces Carium for Developers.

After working with customers to identify the manual workflows driving patient adherence, care team task management and other aspects of their care experience, Carium develops Care Pathways to automate these clinical or operational workflows and make them repeatable.

By tying multiple tools together through these automated pathways, Carium helps customers tap into the full potential of the platform’s broad functionality and seamless integration, improving visibility, flexibility and accessibility for providers and patients.

“Many solutions on the market today offer a solid out-of-the-box experience but limited room for growth, while others require significant, long-term customer development to deliver results,” says Scott Pradels, Chief Technical Officer and Co-Founder of Carium. “We designed Carium to be the best of both worlds—a robust suite of tools to meet immediate needs and a broad platform that scales to support your digital transformation.”

Care Pathways are powered by Carium’s highly configurable orchestration layer, with comprehensive APIs, custom alerting and analytics, and low-code/no-code workflows opening the door to limitless possibilities.

“Our platform is fully driven by APIs and microservices, making it easy for customers to integrate new devices and push/pull data from external sources like EHRs,” says Jessica Shandrowski, Vice President of Product & Customer Success at Carium. “These are the differentiators between a solution that improves patient adherence and operational efficiency—and one that only increases administrative burden for patients and providers.”

These configurable components will enable further customization when Carium makes its developer stack, Carium for Developers, available in a future release. By empowering customers and their development teams to iterate themselves and scale with their needs, Carium will encourage further innovation and evolution of its platform.

“We’ve made a strong commitment to support customer development, and we are working to deliver consumable documentation and an easy-to-use interface that mitigates risk,” says Eko Prasetya, Vice President of Engineering at Carium. “We want to ensure that customers will be able to confidently iterate as safely and easily as we do.”

With its comprehensive out-of-the-box product, light self-service UI personalization, Care Pathways and Carium for Developers, Carium will offer four flexible layers of support for every phase of its customers’ virtual care roadmap.

For further insight into Carium’s development process, read their recently published article Delivering Better Software, Faster.

About Carium
Carium is a Care Experience Platform (CXP) delivering the next generation of advanced virtual care technology. Within one, complete technology ecosystem, the end-to-end care journey – no matter how complex – is person-centric, proactive, and efficient for care teams and the people they serve. Visit us to learn more at carium.com and follow us on LinkedIn or Twitter.

Contact: Ashley Dauwer
401-744-6353
ashley.dauwer@carium.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/carium-enhances-care-experience-platform-with-customizable-care-pathways-301780160.html

SOURCE Carium

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

40 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

41 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

41 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated